The funny thing is that if 2RT were listed on its own, the valuation would probably be much larger than Nova Eye's valuation today. The market has a way of getting imaginative pricing in all the "potential" when the company isn't making money, but as soon as it does start making money it applies a simple multiple to revenue/earnings and completely ignores the pipeline (which is why I really love investing in medical companies currently generating decent revenue, but with a very large pipeline not being priced in at all)
The funny thing is that if 2RT were listed on its own, the...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
-0.003(1.15%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.0¢ | 21.5¢ | $84.25K | 381.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 308826 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 1493 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
21.5¢ |
Change
-0.003 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 22.5¢ | 23.0¢ | 21.5¢ | 151833 | ||
| Last updated 15.15pm 13/06/2024 ? | |||||
| EYE (ASX) Chart |